HER2-targeted monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HER2-targeted monoclonal antibody, covering 2013-02-08 to 2013-02-08. Get the full timeline:
Most recent: Clinical Trial Update: Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2 [Phase 2]